Literature DB >> 26910411

Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.

Carol E DeSantis1, Rebecca L Siegel2, Ann Goding Sauer3, Kimberly D Miller3, Stacey A Fedewa4, Kassandra I Alcaraz5, Ahmedin Jemal6.   

Abstract

In this article, the American Cancer Society provides the estimated number of new cancer cases and deaths for blacks in the United States and the most recent data on cancer incidence, mortality, survival, screening, and risk factors for cancer. Incidence data are from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries, and mortality data are from the National Center for Health Statistics. Approximately 189,910 new cases of cancer and 69,410 cancer deaths will occur among blacks in 2016. Although blacks continue to have higher cancer death rates than whites, the disparity has narrowed for all cancers combined in men and women and for lung and prostate cancers in men. In contrast, the racial gap in death rates has widened for breast cancer in women and remained level for colorectal cancer in men. The reduction in overall cancer death rates since the early 1990s translates to the avoidance of more than 300,000 deaths among blacks. In men, incidence rates from 2003 to 2012 decreased for all cancers combined (by 2.0% per year) as well as for the top 3 cancer sites (prostate, lung, and colorectal). In women, overall rates during the corresponding time period remained unchanged, reflecting increasing trends in breast cancer combined with decreasing trends in lung and colorectal cancer rates. Five-year relative survival is lower for blacks than whites for most cancers at each stage of diagnosis. The extent to which these disparities reflect unequal access to health care versus other factors remains an active area of research. Progress in reducing cancer death rates could be accelerated by ensuring equitable access to prevention, early detection, and high-quality treatment. CA Cancer J Clin 2016;66:290-308.
© 2016 American Cancer Society. © 2016 American Cancer Society, Inc.

Entities:  

Keywords:  cancer statistics; health disparities; incidence; mortality; risk factors; survival; trends

Mesh:

Year:  2016        PMID: 26910411     DOI: 10.3322/caac.21340

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  330 in total

1.  Patient-Level Factors Associated With Lack of Health Care Provider Recommendation for the Human Papillomavirus Vaccine Among Young Cancer Survivors.

Authors:  Jocelyn M York; James L Klosky; Yanjun Chen; James A Connelly; Karen Wasilewski-Masker; Anna R Giuliano; Leslie L Robison; F Lennie Wong; Melissa M Hudson; Smita Bhatia; Wendy Landier
Journal:  J Clin Oncol       Date:  2020-06-18       Impact factor: 44.544

2.  Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.

Authors:  Daniel M Frendl; Mara M Epstein; Hassan Fouayzi; Richard Krajenta; Benjamin A Rybicki; Mitchell H Sokoloff
Journal:  Cancer Causes Control       Date:  2020-06-17       Impact factor: 2.506

3.  Lessons Learned Recruiting Minority Participants for Research in Urban Community Health Centers.

Authors:  Elizabeth Fam; Jeanne M Ferrante
Journal:  J Natl Med Assoc       Date:  2017-07-13       Impact factor: 1.798

4.  Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.

Authors:  Franklin W Huang; Juan Miguel Mosquera; Andrea Garofalo; Coyin Oh; Maria Baco; Ali Amin-Mansour; Bokang Rabasha; Samira Bahl; Stephanie A Mullane; Brian D Robinson; Saud Aldubayan; Francesca Khani; Beerinder Karir; Eejung Kim; Jeremy Chimene-Weiss; Matan Hofree; Alessandro Romanel; Joseph R Osborne; Jong Wook Kim; Gissou Azabdaftari; Anna Woloszynska-Read; Karen Sfanos; Angelo M De Marzo; Francesca Demichelis; Stacey Gabriel; Eliezer M Van Allen; Jill Mesirov; Pablo Tamayo; Mark A Rubin; Isaac J Powell; Levi A Garraway
Journal:  Cancer Discov       Date:  2017-05-17       Impact factor: 39.397

5.  Race and postoperative complications following urologic cancer surgery: An ACS-NSQIP analysis.

Authors:  Daniel C Parker; Elizabeth Handorf; Marc C Smaldone; Robert G Uzzo; Henry Pitt; Adam C Reese
Journal:  Urol Oncol       Date:  2017-09-01       Impact factor: 3.498

6.  Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.

Authors:  Elke J A H van Beek; Jonathan M Hernandez; Debra A Goldman; Jeremy L Davis; Kaitlin McLaughlin; R Taylor Ripley; Teresa S Kim; Laura H Tang; Jaclyn F Hechtman; Jian Zheng; Marinela Capanu; Nikolaus Schultz; David M Hyman; Marc Ladanyi; Michael F Berger; David B Solit; Yelena Y Janjigian; Vivian E Strong
Journal:  Ann Surg Oncol       Date:  2018-05-03       Impact factor: 5.344

Review 7.  Vitamin D3 from Ultraviolet-B Exposure or Oral Intake in Relation to Cancer Incidence and Mortality.

Authors:  William B Grant; Meis Moukayed
Journal:  Curr Nutr Rep       Date:  2019-09

8.  Endometrial cancer outcomes among non-Hispanic US born and Caribbean born black women.

Authors:  Matthew Schlumbrecht; Marilyn Huang; Judith Hurley; Sophia George
Journal:  Int J Gynecol Cancer       Date:  2019-05-03       Impact factor: 3.437

9.  The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A Focus on Outcomes after Cancer in a Racially Diverse Patient Population.

Authors:  Jennifer L Beebe-Dimmer; Terrance L Albrecht; Tara E Baird; Julie J Ruterbusch; Theresa Hastert; Felicity W K Harper; Michael S Simon; Judith Abrams; Kendra L Schwartz; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-11-27       Impact factor: 4.254

10.  Cancer-Related Risk Perceptions and Beliefs in Texas: Findings from a 2018 Population-Level Survey.

Authors:  Sonia A Cunningham; Robert Yu; Tina Shih; Sharon Giordano; Lorna H McNeill; Ruth Rechis; Susan K Peterson; Paul Cinciripini; Lewis Foxhall; Ernest Hawk; Sanjay Shete
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.